搜尋結果
Ozempic doesn't make everyone thin. That opens up an opportunity for some stocks
CNBC· 14 小時前Here's the hard, cold reality: Despite what the perception is, many people taking GLP-1 ...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 22 小時前Pembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the ...
Bird Flu (H5N1) Explained: Australia’s First Human Case Of Bird Flu Reported In Child
Forbes· 6 日前Here’s the latest news about a global outbreak of H5N1 bird flu that started in 2020, and ...
IT Needs Some Pizza Diplomacy
Forbes· 7 日前MTC client attendees are hyper-focused on keeping short-term costs low. The short-term focus ...
Column: In sleep apnea device litigation, who's getting the $1.1 billion settlement?
Reuters· 5 日前When Philips Respironics in 2021 recalled millions of devices for treating sleep apnea, the ...
SEC Stunner: Ether ETFs Are A Go
Forbes· 4 日前The Securities and Exchange Commission gave three major financial markets permission to list exchange-traded funds based ...